CytoSorbents to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference
CytoSorbents (NASDAQ: CTSO) announced its participation in the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference, taking place September 9-10, 2026 in New York City. CEO Dr. Phillip Chan and CFO Peter Mariani will attend, delivering an investor presentation on September 10 at 2:50pm EST and holding scheduled 1-on-1 meetings with institutional investors and family offices.
Key figures
- Cytosorb devices used cumulative
- 300000
- Countries with cytosorb distribution
- 70+
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.